PRP Survival Guide

Some biological samples in test tubes

Biologicals — FDA First Approval Dates

Editor’s Note — Lise D (Denmark) posted the following lament to the PRP Support Group: “I wish it were easier to find out which [biological medications] are older or newly developed.}

The following is a list of biologicals prescribed to, or considered by, PRP patients. The list is alphabetized by generic name and includes the FIRST APPROVAL DATES by the Federal Drug Administration (FDA). 

It should be noted that the FDA has not approved any biological for the treatment. 

  • adalimumab/Humira® — 12/31/2002
  • brodalumab/Silliq® — 02/15/2017
  • certolizumab/Cimzia® — 04/22/2008
  • dupilmab/Dupixent® — 06/07/2022
  • etanercept/Enbrel® — 11/04/2016
  • golimumab/Simponi® — 04/24/2009
  • guselkumab/Tremfya® — 07/14/2020
  • infliximab/Remicade® — 08/1998
  • ixekizumab/Taltz® — 03/22/2016
  • risankizumab/Skyrizi® — 04/23/2019
  • secukinumab/Cosentyx® — 01/21/2015
  • tildrakizumab/Ilamya® — 03/21/2016
  • ustekinumab/Stelara® — 11/25/2009
  • upadacitinib/Rinvoq® — 08/16/2019